NetworkNewsBreaks – Predictive Oncology Inc. (NA
Post# of 281
(Total Views: 218)
Posted On: 11/18/2019 3:33:02 PM
NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Reports Q3 Results, 58% Revenue Increase
Predictive Oncology (NASDAQ: POAI), an artificial intelligence (“AI”) and data-driven functional precision medicine company with the mission of improving the standard of care for cancer patients through innovative data-driven products and services, on Friday announced its financial results for the quarter ended September 30, 2019 and provided a business update. Among the highlights, the company reported a 58% year-over-year increase in revenue for the quarter ended September 30, 2019, to $522,696 compared with $329,930 for the same period last year. “I am very pleased with the growth and development of our unique assets, Helomics and Tumor Genesis, and the and the increase in international interest in our Skyline products,” Predictive Oncology’s CEO Dr. Carl Schwartz said in the news release. “The future looks very bright.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Predictive Oncology (NASDAQ: POAI), an artificial intelligence (“AI”) and data-driven functional precision medicine company with the mission of improving the standard of care for cancer patients through innovative data-driven products and services, on Friday announced its financial results for the quarter ended September 30, 2019 and provided a business update. Among the highlights, the company reported a 58% year-over-year increase in revenue for the quarter ended September 30, 2019, to $522,696 compared with $329,930 for the same period last year. “I am very pleased with the growth and development of our unique assets, Helomics and Tumor Genesis, and the and the increase in international interest in our Skyline products,” Predictive Oncology’s CEO Dr. Carl Schwartz said in the news release. “The future looks very bright.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)